DJIA 18,265.04 -20.70 -0.11%
NASDAQ 5,099.57 8.77 0.17%
S&P 500 2,130.60 -0.22 -0.01%
market minute promo

ONCONOVA THERAPEUTICS INC (NASDAQ: ONTX)

2.77 0.03 (1.09%)

Quote as of


company name or ticker

Recent Quotes

ONTX $2.77 1.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.74
Previous Close $2.74
Daily Range $2.71 - $2.77
52-Week Range $2.15 - $5.78
Market Cap $60.1M
P/E Ratio -1.04
Dividend (Yield) $0.00 (0.0%)
Volume 7,690
Average Daily Volume 41,793
Current FY EPS -$1.86

Sector

Industry

ONCONOVA THERAPEUTICS INC (ONTX) Description

ONCONOVA THERAPEUTICS INC Website: http://www.onconova.com/

News & Commentary Rss Feed

This Week in Biotech: Buyouts, an FDA Approval, and Clinical Data. Oh, My!

A $25 billion buyout, a long-awaited FDA approval, two positive clinical studies, and one biopharma losing 37% of its value, are this week's top biotech stories.

Onconova Therapeutics (ONTX) Looks Good: Stock Up 5.8% - Tale of the Tape

Onconova Therapeutics (ONTX) Shares March Higher, Can It Continue? - Tale of the Tape

Onconova Therapeutics (ONTX) Shares March Higher, Can It Continue? - Tale of the Tape

What's in Store for Autodesk (ADSK) in Q1 Earnings? - Analyst Blog

Why Onconova Therapeutics (ONTX) Might Surprise This Earnings Season - Tale of the Tape

Will Kite Pharma (KITE) Miss Earnings Estimates Yet Again? - Analyst Blog

Will Immune Design (IMDZ) Miss on Earnings This Season? - Analyst Blog

Health Care Sector Update for 05/05/2015: ONTX,PTBI,ARCX

H.C Wainwright Initiates Onconova Therapeutics At Buy

Onconova Therapeutics, Inc. Submits Pivotal Clinical Trial Protocol for IV Rigosertib in Higher-Risk

Onconova Therapeutics, Inc. Submits Pivotal Clinical Trial Protocol for IV Rigosertib in Higher-Risk Myelodysplastic Syndromes to FDA and EMA

Onconova Therapeutics, Inc. (ONTX) Rises: Stock Up 11.4% - Tale of the Tape

See More ONTX News...